DH
David Hoang Deutsche Bank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
64.3%
Neutral
14.3%
Negative
21.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $90 |
43%
upside
| 1 | 0% |
0
%
| 10 Mar ‘26 5 hours ago |
|
|
|
Buy
Initiated
| $103 |
37%
upside
| 1 | +0.27% |
0
%
| 10 Dec ‘25 3 months ago |
|
|
|
Buy
Maintained
| $45 |
58%
upside
| 2 | -8.1% |
0
%
| 13 Nov ‘25 3 months ago |
|
|
|
Buy
Maintained
| $280 |
9%
downside
| 1 | +90% |
0
%
| 17 Oct ‘25 4 months ago |
|
|
|
Buy
Initiated
| $43 |
5%
upside
| 1 | +163% |
0
%
| 26 Sep ‘25 5 months ago |
|
|
|
Buy
Maintained
| $36 |
26%
upside
| 2 | -7.6% |
0
%
| 25 Sep ‘25 5 months ago |
|
|
|
Sell
Maintained
| $12 |
32%
downside
| 5 | -12% |
0
%
| 15 Aug ‘25 6 months ago |
|
|
|
Buy
Upgraded
| $35 |
55%
upside
| 1 | +4.1% |
0
%
| 21 May ‘25 9 months ago |
|